Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
205 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Protozoan Infections" (205 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Cryptosporidiosis and Enteropathogens in Bangladesh
Condition: Cryptosporidiosis
Intervention:
2 Unknown  Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
3 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
4 Not yet recruiting Severe and Cerebral Malaria Investigated Through Host Metabolomics
Condition: Severe Malaria
Intervention: Other: Observation
5 Unknown  Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
6 Unknown  Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
7 Unknown  Randomized Trial of Erythropoietin During Cerebral Malaria
Condition: Cerebral Malaria
Interventions: Drug: Placebo;   Drug: Erythropoietin
8 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
9 Not yet recruiting Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis
Condition: Coccidioidomycosis
Intervention: Drug: Sertraline
10 Recruiting A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAP
Condition: Malaria
Interventions: Biological: 10 µg R21/ 50 µg Matrix M1;   Biological: 50 µg R21/ 50 µg Matrix M1;   Biological: 10 µg R21/ 50 µg Matrix M1 with ChAd63-MVA ME-TRAP and MVA ME-TRAP
11 Not yet recruiting Use of Malaria Rapid Diagnostic Tests as a Decision Aid for the Management of Fever by International Travelers
Conditions: Fever;   Malaria
Intervention: Device: rapid diagnostic test for malaria antigen
12 Not yet recruiting Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1
Condition: Malaria
Intervention: Drug: Primaquine, R-Primaquine, S-Primaquine, SR Primaquine
13 Not yet recruiting Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance Markers
Condition: Plasmodium Falciparum
Intervention:
14 Not yet recruiting A Study of a New Leishmania Vaccine Candidate ChAd63-KH
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: ChAd63-KH
15 Not yet recruiting MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria
Condition: Malaria
Intervention: Drug: MMV390048
16 Not yet recruiting RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission
Condition: Malaria
Intervention: Biological: dihydroartemisinin-piperaquine
17 Not yet recruiting G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria
Condition: Vivax Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine 0.25 mg/kg/day;   Drug: Primaquine 0.75 mg/kg weekly
18 Recruiting SJ733 Induced Blood Stage Malaria Challenge Study
Condition: Plasmodium Falciparum Malaria
Intervention: Drug: (+)-SJ000557733
19 Not yet recruiting Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis
Conditions: Toxoplasmosis Infection;   Genotype II;   Ocular Toxoplasmosis With Recurrences
Intervention: Biological: seropositive for Toxoplasma gondii
20 Not yet recruiting Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.
Condition: Malaria
Interventions: Biological: PfSPZ Vaccine;   Biological: PfSPZ Challenge (for CHMI);   Other: Normal Saline;   Biological: PfSPZ Challenge (for PfSPZ-CVac)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years